Skip to main content
. 2023 Oct 5;18(10):e0287766. doi: 10.1371/journal.pone.0287766

Fig 5. Weighted RPL mean preference results with 95% CIs (N = 323).

Fig 5

CIs = Confidence intervals; IV = Intravenous; CAR-T = Chimeric Antigen Receptor; BiTE® = Bispecific T-Cell Engager; ADC = Anti-Drug Conjugate PFS = Progression-free survival; GI = Gastrointestinal, CNS = Central Nervous System; CRS = Cytokine Release Syndrome.